Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Ardea Biosciences, Inc./DE
| Metric | Ardea Biosciences, Inc./DE Healthcare |
|---|---|
| Quality Score | 40 / 100 |
| Revenue (latest) | $7M |
| Net income (latest) | −$87M |
| Operating margin | −1186.3% |
| Net margin | −1185.2% |
| Return on equity | −105.3% |
| Return on assets | −83.1% |
| Return on capital (ROCE) | −104.8% |
| Debt / equity | — |
| Revenue growth (YoY) | −73.4% |
| Altman Z″ (distress) | — |
| Accruals / assets | −25.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.